APH1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.94250001931351E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.86729999971125E-07 |
Normal-vs-Stage2 |
2.55979999996825E-06 |
Normal-vs-Stage3 |
1.24889987240806E-10 |
Normal-vs-Stage4 |
1.9177992527375E-11 |
Stage1-vs-Stage2 |
7.067800E-01 |
Stage1-vs-Stage3 |
6.37679999999641E-05 |
Stage1-vs-Stage4 |
3.88439999998713E-06 |
Stage2-vs-Stage3 |
1.918030E-02 |
Stage2-vs-Stage4 |
4.398800E-03 |
Stage3-vs-Stage4 |
3.276800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.59990001433886E-09 |
Normal-vs-AfricanAmerican |
3.26640000047895E-07 |
Normal-vs-Asian |
4.235300E-04 |
Caucasian-vs-AfricanAmerican |
7.083400E-01 |
Caucasian-vs-Asian |
8.334000E-01 |
AfricanAmerican-vs-Asian |
9.805400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.15819999649369E-08 |
Normal-vs-Female |
2.34310004731952E-09 |
Male-vs-Female |
1.772400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.231400E-04 |
Normal-vs-Age(41-60Yrs) |
1.4243999979513E-08 |
Normal-vs-Age(61-80Yrs) |
1.00120000068316E-08 |
Normal-vs-Age(81-100Yrs) |
1.68659999966181E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.706000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.404400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.938600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.428600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.480800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.341200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.528200E-02 |
Normal-vs-Grade 2 |
6.98469999949047E-07 |
Normal-vs-Grade 3 |
3.2688995954544E-10 |
Normal-vs-Grade 4 |
3.08852943220472E-12 |
Grade 1-vs-Grade 2 |
2.398200E-01 |
Grade 1-vs-Grade 3 |
3.479500E-03 |
Grade 1-vs-Grade 4 |
2.013400E-04 |
Grade 2-vs-Grade 3 |
1.029400E-04 |
Grade 2-vs-Grade 4 |
2.40069999990489E-07 |
Grade 3-vs-Grade 4 |
1.940250E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.5509999990756E-08 |
Normal-vs-ccB subtype |
3.00299999977938E-07 |
ccA subtype-vs-ccB subtype |
7.943200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.05989999502165E-08 |
Normal-vs-N1 |
1.523970E-02 |
N0-vs-N1 |
8.648400E-01 |
|
|